Search
Tofogliflozin
go.drugbank.com/drugs/DB11824InvestigationalTofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.
Categories: Sodium-Glucose Transporter 2 InhibitorsRuboxistaurin
go.drugbank.com/drugs/DB11829InvestigationalRuboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingMocetinostat
go.drugbank.com/drugs/DB11830InvestigationalMocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.
Categories: Heterocyclic Compounds, 1-RingCrenolanib
go.drugbank.com/drugs/DB11832InvestigationalCrenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSapanisertib
go.drugbank.com/drugs/DB11836InvestigationalSapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingLucitanib
go.drugbank.com/drugs/DB11845InvestigationalLucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Categories: Heterocyclic Compounds, 2-RingBafetinib
go.drugbank.com/drugs/DB11851InvestigationalBafetinib has been used in trials studying the treatment of Adult Gliosarcoma, Adult Mixed Glioma, Adult Glioblastoma, Chronic Myeloid Leukemia, and Acute Lymphocytic Leukemia, among others.
Categories: Heterocyclic Compounds, 1-RingTegobuvir
go.drugbank.com/drugs/DB11852InvestigationalTegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingRelugolix
go.drugbank.com/drugs/DB11853ApprovedInvestigationalRelugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. … currently only) orally-administered GnRH receptor antagonist approved for the treatment of prostate cancer - similar therapies such as [degarelix] require subcutaneous administration - and therefore provides a
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesLeukotriene D4
go.drugbank.com/drugs/DB11858InvestigationalLeukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.
Synonyms: (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine, S-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-L-cysteinylglycineCategories: SRS-A